Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CRSP stock hub

CRISPR Therapeutics AG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CRSPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.3B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CRSP

In the news

Latest news · CRSP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-31.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-351.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CRSP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001674416
Company name	CRISPR Therapeutics AG
Country	Switzerland
Country code	US
Cusip	H17182108
Employees	393
Employees Change	-14%
Employees Change Percent	-3.44
Enterprise value	$3.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2016-10-19
Isin	CH0334081137
Last refreshed	2026-05-10
Market cap	$5.3B
Market cap category	Mid-Cap
Price	$54.83
Price currency	USD
Rev Per Employee	10,440.2x
Sector	Healthcare
Sic	2836
Symbol	CRSP
Website	https://www.crisprtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.75%
EV Sales Forward	92.23x
EV/Sales	885.73x
FCF yield	-7.59%
P/B ratio	2.91x
P/S ratio	1,288.88x
PS Forward	134.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-478.7M
Net Income	$-568.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-13,774.56%
Profit Per Employee	$-1.4M
ROA	-14.06
Roa5y	-8.33
ROCE	-21.24
ROE	-31.21
Roe5y	-13.88
ROIC	-351.4
Roic5y	-91.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	60.14%
Cagr3y	-0.58%
Cagr5y	-12.63%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-89.11x
Revenue Growth Q	68.56x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-65.54x
Revenue Growth5 Y	30.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$2.7B
Cash	$2.4B
Current Assets	$2.4B
Current Liabilities	$136.3M
Debt	$787.6M
Debt Equity	$0.43
Equity	$1.8B
Liabilities	$911.3M
Long Term Assets	$277.5M
Long Term Liabilities	$775M
Net Cash	$1.7B
Net Cash By Market Cap	$31.28
Net Cash Growth	1.11%
Net Debt Equity	$-0.91
Tangible Book Value	$1.8B
Tangible Book Value Per Share	$18.83
WACC	12.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	17.96
Net Working Capital	$-111.1M
Quick ratio	17.92
Working Capital	$2.3B
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.27%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	60.09%
200-day SMA	56.2
3Y total return	-1.72%
50-day SMA	52.21
50-day SMA vs 200-day SMA	50under200
5Y total return	-49.09%
All Time High	220.2
All Time High Change	-75.1%
All Time High Date	2021-01-15
All Time Low	11.63
All Time Low Change	371.45%
All Time Low Date	2017-02-15
ATR	3.03
Beta	1.74
Beta1y	1.86
Beta2y	1.85
Ch YTD	4.56
High	55.85
High52	78.48
High52 Date	2025-10-08
High52ch	-30.14%
Low	52.55
Low52	34.12
Low52 Date	2025-05-08
Low52ch	60.7%
Ma50ch	5.01%
Premarket Change Percent	0.46
Premarket Price	$52.66
Premarket Volume	11,243
Price vs 200-day SMA	-2.44%
RSI	54.31
RSI Monthly	51.02
RSI Weekly	51.69
Sharpe ratio	1x
Sortino ratio	1.69
Total Return	-8.27%
Tr YTD	4.56
Tr1m	10.32%
Tr1w	6.2%
Tr3m	12.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	16
Analyst Count Top	5
Analyst Price Target Top	$83.4
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.22
Earnings Revenue Estimate	5,064,544x
Earnings Revenue Estimate Growth	485.5x
Operating Income	$-550.1M
Operating margin	-13,408.3
Price target	$72.06
Price Target Change	$31.42
Price Target Change Top	$52.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,018,164%
Float Percent	99.55%
Net Borrowing	600,000,000
Shares Insiders	0.45%
Shares Institutions	79.55%
Shares Out	96,448,792
Shares Qo Q	0.82%
Shares Yo Y	8.27%
Short Float	23.7%
Short Ratio	13.95
Short Shares	23.59

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-469.8M
Average Volume	1,934,523.15x
Bv Per Share	18.83
CAPEX	$-1.2M
Ch1m	10.32
Ch1w	6.2
Ch1y	60.09
Ch3m	12.5
Ch3y	-1.72
Ch5y	-49.09
Ch6m	-0.53
Change	4.6%
Change From Open	3.36
Close	52.42
Days Gap	1.2
Depreciation Amortization	19,062,000
Dollar Volume	95,041,060.9
Earnings Date	2026-05-04
Earnings Time	amc
EBIT	$-550.1M
EBITDA	$-531.1M
EPS	$-6.15
F Score	2
FCF	$-401.2M
FCF EV Yield	-11.04x
FCF Per Share	$-4.16
Financing CF	1,007,346,000
Fiscal Year End	December
Founded	2,013
Income Tax	$3.4M
Investing CF	-422,793,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-12
Ma150	55.63
Ma150ch	-1.44%
Ma20	54.09
Ma20ch	1.37%
Net CF	184,611,000
Next Earnings Date	2026-08-03
Open	53.05
Optionable	Yes
Position In Range	69.09
Post Close	54.83
Postmarket Change Percent	-0.44
Postmarket Price	$54.59
Ppne	240,846,000
Pre Close	52.42
Price Date	2026-05-08
Ptbv Ratio	2.91
Relative Volume	0.9x
Revenue	4,103,000x
SBC By Revenue	1,672.22x
Share Based Comp	68,611,000
Tax By Revenue	81.99x
Tr6m	-0.53%
Volume	1,733,377
Z Score	2.47

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CRSP pay a dividend?

Capital-return profile for this ticker.

Performance

CRSP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CRSP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+79.6%

Float: +99.6% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CRSP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.3

Neutral momentum band

Price vs 200-day MA

-2.4%

50/200-day relationship not available

Beta (5Y)

1.74

More volatile than the market

Sharpe ratio

1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CRSP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CRSP stock rating?

CRISPR Therapeutics AG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CRSP analysis?

The full report lives at /stocks/CRSP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CRSP?

The latest report frames CRSP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CRSP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.